Clinical Trial

Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)

Name: Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG) — clinical trial record (NCT07413835)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This is an open label, single arm study, to evaluate the safety , tolerability and preliminary efficacy of HN2302 for refractory myasthenia gravis.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-13.

Status change: Not Yet Recruiting → Recruiting 2026-03-16

Trial Details

NCT Number	NCT07413835
Lead Sponsor	The Affiliated Hospital of Xuzhou Medical University Collaborators: Shenzhen MagicRNA Biotechnology Co., Ltd
Conditions	Refractory Myasthenia Gravis
Enrollment	6 participants
Start Date	2026-03-17
Primary Completion	2027-06 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-03-18